Picture of Repligen logo

RGEN — Repligen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Repligen Q2 Adjusted EPS USD 0.33 Vs. IBES Estimate USD 0.33

Jul 30 (Reuters) - Repligen Q2 revenue USD 154 million vs. IBES estimate USD
154.1 million.
* Q2 adjusted net income USD 19 million vs. IBES estimate USD 18.5 million
* Q2 adjusted operating income USD 16 million vs. IBES estimate USD 19.1
million

Recent news on Repligen

See all news